The health care reform bill passed by the House this weekend now moves to the Senate, which has its own version of a bill. So how do investors play health care stocks? Les Funtleyder, health care strategist for Miller Tabak and Ipsita Smolinksi, health care analyst for Capitol Street gave their outlook on Monday to CNBC. Read More
China's Shanghai Index up 2.7 percent as Chinese PMI was stronger than expected. U.S. ISM will be released at 10 Am ET. And that's the point: with earnings season just about over, it is economic news that will be the driver for the next couple of months. Read More
Worries over health care reform have caused the sector to be underowned, but there are still opportunities for investors looking to take advantage of the low prices, said Charles Boorady of Citigroup and Arthur Henderson of Jeffries & Co. Read More
The day after President Obama’s impassioned speech for big-government health care, Wall Street bet heavily that the so-called government-insurance option he supports is dead. Read More
Shares of U.S. health insurers climbed as analysts said Pres. Barack Obama's highly anticipated speech urging Congress to act on health reform revealed no "game changers." Thomas Carroll, analyst at Stifel Nicolaus, and David Joy, chief market strategist at RiverSource Investments, shared their insights on the industry. Read More
As the health care debate continues, Todd Weller, health care IT analyst at Stifel Nicolaus, and Les Funtleyder, health care strategist at Miller Tabak, zero in on health care names that may bring healthy returns. Read More